Prognostic value of LIPC in non-small cell lung carcinoma

Non-small cell lung carcinoma (NSCLC) is the most common form of lung cancer and is associated with a high mortality rate worldwide. The majority of individuals bearing NSCLC are treated with surgery plus adjuvant cisplatin, an initially effective therapeutic regimen that, however, is unable to prev...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Galluzzi, Lorenzo, Goubar, Aicha, Olaussen, Ken André, Vitale, Ilio, Senovilla, Laura, Michels, Judith, Robin, Angélique, Dorvault, Nicolas, Besse, Benjamin, Validire, Pierre, Fouret, Pierre, Behrens, Carmen, Wistuba, Ignacio Ivan, Soria, Jean-Charles, Kroemer, Guido
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2013
Teme:
Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594265/
https://ncbi.nlm.nih.gov/pubmed/23343765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.23517
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items